Today, 85 years after its foundation, Corporación Farmacéutica Recalcine is the leading company in the pharmaceutical market in Chile. It is constantly developing biotechnology projects and clinical studies, supported by the main forming entities in Chile and abroad.
Corporación Farmacéutica Recalcine inaugurated in September 2006 the CFR Pharmafuturo Pharmaceutical Complex, with the purpose to become the first Latin American laboratory with a global presence and research of its own. CFR Pharmafuturo Pharmaceutical Complex was designed according to the GMP (Good Manufacturing Practice)
HSMI evidence detected in farmed salmon Canada
A team of international researchers has diagnosed a potential heart and skeletal muscle inflammation in farmed Atlantic salmon samples collected from a BC aquaculture facility in 2013-2014.